FOS and cancer: We have proven that TFII‐I was a key partner for circARHGAP35 protein to exert its oncogenic functions, thereby demonstrating the need for the circARHGAP35 protein by cancer cell lines to establish and maintain an oncogenic transcriptome (e.g., FOS).